Ana O Hoff

Summary

Country: Brazil

Publications

  1. ncbi Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates
    Ana O Hoff
    Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    J Bone Miner Res 23:826-36. 2008
  2. ncbi Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients
    Ana O Hoff
    Department of Endocrinology, Fleury Group, Brazil
    Ann N Y Acad Sci 1218:47-54. 2011
  3. ncbi Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer
    Libero Santarpia
    Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Head Neck 31:419-23. 2009
  4. ncbi [Importance of parathyroid SPECT and 99mTc scintigraphy, and of clinical, laboratorial, ultrasonographic and citologic correlation in the pre-operative localization of the parathyroid adenoma - pictorial assay]
    Marco Antonio Conde de Oliveira
    Serviços de Medicina Nuclear, Fleury Medicina e Saúde, Sao Paulo, SP, Brasil
    Arq Bras Endocrinol Metabol 54:352-61. 2010
  5. ncbi Thyrotoxicosis after denileukin diftitox therapy in patients with mycosis fungoides
    Farah Ghori
    Department of Dermatology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 434, Houston, Texas 77030, USA
    J Clin Endocrinol Metab 91:2205-8. 2006
  6. ncbi Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein a
    Mouhammed Amir Habra
    Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Endocr Pract 14:1108-14. 2008
  7. ncbi Osteoporosis in breast and prostate cancer survivors
    Ana O Hoff
    Department of Endocrine Neoplasia and Hormonal Disorders, M D Anderson Cancer Center, Houston, TX 77030, USA
    Oncology (Williston Park) 19:651-8. 2005
  8. ncbi RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors
    Maria A Kouvaraki
    Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77230-1402, USA
    Thyroid 15:531-44. 2005

Collaborators

  • Douglas B Evans
  • Madeleine Duvic
  • Kadri Altundag
  • Valentina Guarneri
  • Libero Santarpia
  • G N Hortobagyi
  • Robert F Gagel
  • Marco Antonio Conde de Oliveira
  • Mouhammed Amir Habra
  • Gilbert J Cote
  • Farah Ghori
  • Steven I Sherman
  • Maria A Kouvaraki
  • Paola Smanio
  • Cynthia M A Brandão
  • Patricia Dreyer
  • Alberto Lobo
  • Victor Piana de Andrade
  • José G Vieira
  • Rosa Paula Mello Biscolla
  • Sérgio Setsuo Maeda
  • Camilo Jimenez
  • William A Murphy
  • Su Chen Eileen Huang
  • Kristel D Polder
  • Lauren C Pinter-Brown
  • Suzanne E Shapiro
  • Jeffrey E Lee
  • Nancy D Perrier

Detail Information

Publications8

  1. ncbi Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates
    Ana O Hoff
    Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    J Bone Miner Res 23:826-36. 2008
    ..Osteonecrosis of the jaw (ONJ) has been reported in patients treated with bisphosphonates. The incidence and risk factors associated with this disorder have not been clearly defined...
  2. ncbi Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients
    Ana O Hoff
    Department of Endocrinology, Fleury Group, Brazil
    Ann N Y Acad Sci 1218:47-54. 2011
    ..In this review, we summarize the reported incidence and risk factors associated with ONJ...
  3. ncbi Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer
    Libero Santarpia
    Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Head Neck 31:419-23. 2009
    ..Medullary thyroid cancer (MTC) commonly metastasizes to lymph nodes in the central and lateral neck, but spread to distant organs also occurs, typically involving lung, liver, and bone. Metastases to pituitary gland are rare for this tumor...
  4. ncbi [Importance of parathyroid SPECT and 99mTc scintigraphy, and of clinical, laboratorial, ultrasonographic and citologic correlation in the pre-operative localization of the parathyroid adenoma - pictorial assay]
    Marco Antonio Conde de Oliveira
    Serviços de Medicina Nuclear, Fleury Medicina e Saúde, Sao Paulo, SP, Brasil
    Arq Bras Endocrinol Metabol 54:352-61. 2010
    ..In patients with primary hyperparathyroidism, candidates for surgical intervention, the parathyroid pre-operative localization is of fundamental importance in planning the appropriate surgical approach...
  5. ncbi Thyrotoxicosis after denileukin diftitox therapy in patients with mycosis fungoides
    Farah Ghori
    Department of Dermatology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 434, Houston, Texas 77030, USA
    J Clin Endocrinol Metab 91:2205-8. 2006
    ..CONCLUSIONS: Monitoring thyroid function before and during treatment with denileukin diftitox is recommended. Symptomatic thyrotoxicosis may be missed due to other acute reactions to the drug, and subsequent hypothyroidism may develop...
  6. ncbi Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein a
    Mouhammed Amir Habra
    Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Endocr Pract 14:1108-14. 2008
    ..To evaluate the expression of various phosphaturic factors in the tumor of a patient with tumor-induced osteomalacia (TIO) and to analyze serum levels of fibroblast growth factor (FGF)-23 in TIO and healthy subjects...
  7. ncbi Osteoporosis in breast and prostate cancer survivors
    Ana O Hoff
    Department of Endocrine Neoplasia and Hormonal Disorders, M D Anderson Cancer Center, Houston, TX 77030, USA
    Oncology (Williston Park) 19:651-8. 2005
    ..This article will address the characteristics of bone loss observed in breast and prostate cancer patients and potential treatments...
  8. ncbi RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors
    Maria A Kouvaraki
    Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77230-1402, USA
    Thyroid 15:531-44. 2005
    ..Recommendations on the timing of prophylactic thyroidectomy and the extent of surgery are based upon a model that utilizes genotype- phenotype correlations to stratify mutations into three risk levels...